CoQ10 and Exercise for Mitochondrial Dysfunction in Advance Kidney Disease

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 156 participants.

Also called NCT05422534

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose prevention
Phase
Phase 3
Enrolled
  • 156 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05422534
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT05422534. Randomized; double masking; primary purpose prevention. Start 2023-06-01 (actual); primary completion 2027-06-20 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
CoQ10 and Exercise for Mitochondrial Dysfunction in Advance Kidney Disease
Condition
End Stage Renal Disease
Intervention (Dietary supplement)
CoQ10
Intervention (Drug)
Placebo
Intervention (Behavioral)
HB-HIIT
Intervention (Behavioral)
Observational
Lead sponsor
Vanderbilt University Medical Center (class: other)
Collaborator
University of California, Davis (class: other)

Record details

Record id
cardio:ct-nct05422534
Content hash
1ea70b8fa8490e05f69d77ae1115e569b0ec8b4879aa8bd32e4b47a1482dfd49